For our EP Protocol (Enclomiphene + Pregnenelone), there is less risk of hair loss compared to some other testosterone-increasing treatments, but there is never zero risk.
​
The research suggests that the medications used in our protocol do not increase the DHT: T ratio, so it should not affect your hair or prostate as much as Testosterone Replacement Therapy (TRT), which increases the DHT: T ratio significantly.
​
Thus, Maximus' EP Protocol (Enclomiphene + Pregnenelone) is relatively hair and prostate safe/friendly, and should not have any contraindications with any related medications.